NASDAQ · Biotechnology
Structure Therapeutics Inc. American Depositary Shares (GPCR)
$16.13
-5.78%
25
Oversold
Moving averages
SMA 200$46.63-65.41%
Company profile
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company is headquartered in South San Francisco, California.
SectorHealthcare
IndustryBiotechnology
Market cap$1.49B
P/E ratioNone
EPS$-3.77
Beta-1.197
Dividend yield0.00%
52-week high$94.90
52-week low$18.70
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
NTLA
Intellia Therapeutics Inc
RSI 37
NVAX
Novavax Inc
RSI 33
GHRS
GH Research PLC
RSI 41
SRPT
Sarepta Therapeutics Inc
RSI 29
ANRO
Alto Neuroscience Inc
RSI 52
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 48
RSI alerts for GPCR
An email when GPCR closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 4:53 AM EST